[ad_1]
New insulin promises stable blood glucose control, day and night
The new insulin promises stable blood glucose control throughout the day and night. PHOTO: FILE
KARACHI: Sanofi has announced the introduction of its new generation of basal insulin (insulin glargine U300) in Pakistan at a scientific event attended by reputed physicians. Blood glucose control in diabetic patients remains suboptimal. Sanofi's new basal insulin, designed to work for 24 hours, seeks to address this unmet need. This basal insulin was approved by the FDA in 2015 and since then has been introduced in many countries, including the United States, Canada, Russia, Japan and India. Sanofi's insulin glargine U300 is similar to the body's natural insulin and helps control blood sugar, as well as diet and exercise. The new insulin promises stable blood glucose control throughout the day and night. Sanofi Pakistan President and CEO Asim Jamal said, "We have been helping people with diabetes in Pakistan for more than 50 years through oral treatments and insulin treatments for over 40 years. ;a decade. We strive to bring innovative solutions to patients to improve their health. "
Posted in The Express Tribune, January 26th, 2019.
As Business on Facebook, to follow @TribuneBiz on Twitter to stay informed and participate in the conversation.
[ad_2]
Source link
